Hem › Kronisk myeloisk leukemi › Washington › Seattle
Kliniska studier för Kronisk myeloisk leukemi i Seattle, WA
11 studier för Kronisk myeloisk leukemi söker deltagare vid platser i och runt Seattle (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekryterarObservationsstudieFriska volontärer välkomna
- Swedish Medical Center-Ballard Campus, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- Swedish Medical Center-First Hill, Seattle
- och 1 fler
Study of Olverembatinib (HQP1351) in Patients With CML-CP
RekryterarFas 3
- Ascentage Investigative Site #1806, Seattle
- Ascentage Investigative Site #1510, Seattle
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
RekryterarFas 2
- Seattle Childrens Hospital, Seattle
Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases
RekryterarFas 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RekryterarObservationsstudie
- Fred Hutchinson Cancer Research Center, Seattle
Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
RekryterarFas 2Friska volontärer välkomna
- Fred Hutch/University of Washington Cancer Consortium, Seattle
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
RekryterarFas 1
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
RekryterarFas 2
- Fred Hutchinson Cancer Center, Seattle
A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)
RekryterarFas 1/2
- Fred Hutchinson Cancer Center, Seattle
Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
RekryterarFas 1
- Fred Hutchinson Cancer Research Center, Seattle
TGRX-678 US Phase I for Subjects with Refractory or Advanced Chronic Myelogenous Leukemia
RekryterarFas 1
- Fred Hutchinson Cancer Center, Seattle
Kronisk myeloisk leukemi-studier i andra städer
- Houston, TX18 studier
- New York City, NY11 studier
- Detroit, MI6 studier
- Birmingham, AL6 studier
- Philadelphia, PA6 studier
- Chicago, IL6 studier
- Baldwin Park, CA6 studier
- Portland, OR6 studier
- Nashville, TN5 studier
- Columbus, OH5 studier
- Milwaukee, WI5 studier
- Baltimore, MD5 studier
Andra studier i Seattle
- Icke-småcellig lungcancer53 studier
- Cancer (alla typer)49 studier
- Prostatacancer42 studier
- Akut myeloid leukemi40 studier
- Bröstcancer39 studier
- Metastaserande cancer39 studier
- Kolorektal cancer34 studier
- Lungcancer33 studier
- Äggstockscancer30 studier
- Multipelt myelom22 studier
- Myelodysplastiska syndrom21 studier
- Akut lymfoblastisk leukemi21 studier
Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.